Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Highly active antiretroviral therapy started in infants under 3 months of age: 72-week follow-up for CD4 cell count, viral load and drug resistance outcome.

Aboulker JP, Babiker A, Chaix ML, Compagnucci A, Darbyshire J, Debré M, Faye A, Giaquinto C, Gibb DM, Harper L, Saïdi Y, Walker AS; Paediatric European Network for Treatment of AIDS.

AIDS. 2004 Jan 23;18(2):237-45.

PMID:
15075541
2.

Genotypic resistance tests in the management of the HIV-infected patient at virological failure.

Aceti A, Carosi G.

Scand J Infect Dis Suppl. 2003;106:61-6. Review.

PMID:
15000587
4.

Primary HIV infection in infants: impact of highly active antiretroviral therapy on the natural course.

De Rossi A.

J Biol Regul Homeost Agents. 2002 Jan-Mar;16(1):53-7. Review.

PMID:
12003175
5.

Patients who want to stop their medications: treatment interruptions in HIV infection.

Ball SC.

AIDS Read. 2003 Jul;13(7):317-9, 324, 342. Review. No abstract available.

PMID:
12889449
6.

Biologic effects and safety of stavudine: overview of phase I and II clinical trials.

Skowron G.

J Infect Dis. 1995 Mar;171 Suppl 2:S113-7. Review.

PMID:
7861015
7.

HIV therapeutics in children and adults and their side effects.

Laurence J.

AIDS Read. 2004 Jan;14(1):6-7. Review. No abstract available.

PMID:
14959697
8.

Optimizing efficacy and tolerability in today's HAART.

Pozniak A.

AIDS Read. 2003 Sep:S4-8. Review. No abstract available.

PMID:
14601553
9.

Recent research in HIV infection: Part I.

Boyle BA.

AIDS Read. 2002 Nov;12(11):477-8, 483-5. Review. No abstract available.

PMID:
12494908
10.

[Advance and perspective of antiretroviral therapy].

Tsukada K, Oka S.

Nihon Rinsho. 2010 Mar;68(3):389-94. Review. Japanese.

PMID:
20229779
11.
12.

Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era.

Jong E, Oudhoff LA, Epskamp C, Wagener MN, van Duijn M, Fischer S, van Gorp EC.

AIDS. 2010 Jun 19;24(10):1387-405. doi: 10.1097/QAD.0b013e328339d004. Review.

PMID:
20523204
13.

Highly active antiretroviral therapy in neonates and young infants.

Bell GS.

Neonatal Netw. 2004 Mar-Apr;23(2):55-64. Review.

PMID:
15077862
14.

Monitoring of highly active antiretroviral therapy in HIV infection.

Walker AS, Gibb DM.

Curr Opin Infect Dis. 2011 Feb;24(1):27-33. doi: 10.1097/QCO.0b013e3283423e0e. Review.

PMID:
21150591
15.

HIV update 2002: delaying treatment to curb rising resistance.

Armstrong W, Calabrese L, Taege A.

Cleve Clin J Med. 2002 Dec;69(12):995-9. Review.

PMID:
12546273
16.

Pulse therapy.

Laurence J.

AIDS Read. 2004 Feb;14(2):57-8. Review. No abstract available.

PMID:
14997858
17.

Salvage therapy for HIV infection: when and how.

Núñez M, Soriano V.

AIDS Patient Care STDS. 2000 Sep;14(9):465-76. Review. No abstract available.

PMID:
11051629
18.

[HIV-related symptoms].

Potthoff A, Brockmeyer NH.

Urologe A. 2006 Dec;45(12):1521-6. Review. German.

PMID:
17119897

Supplemental Content

Support Center